| Description |
1 online resource |
| Contents |
Intro -- Preface -- Contents -- Editors and Contributors -- 1: Introduction to Lung Disease -- 1.1 Introduction -- 1.2 Overview of Lung Disease -- 1.2.1 Chronic Obstructive Pulmonary Disease -- 1.2.1.1 Etiology -- 1.2.1.2 The Genetic Origins -- 1.2.1.3 MicroRNAs ́Origins -- 1.2.1.4 Pathophysiology -- 1.2.1.5 Treatment -- 1.2.2 Asthma -- 1.2.2.1 Etiology -- 1.2.2.2 Epidemiology (Hernandez-Gonzalez et al. 2021 -- Hoffman 2021) -- 1.2.2.3 Pathophysiology -- 1.2.2.4 Treatment -- 1.2.3 Pneumonia -- 1.2.3.1 Etiology -- 1.2.3.2 Epidemiology -- 1.2.3.3 Pathophysiology -- 1.2.3.4 Treatment |
|
1.2.4 Tuberculosis -- 1.2.4.1 Etiology -- 1.2.4.2 Epidemiology -- 1.2.4.3 Pathophysiology -- 1.2.4.4 Treatment -- 1.2.5 Cystic Fibrosis -- 1.2.5.1 Etiology -- 1.2.5.2 Epidemiology -- 1.2.5.3 Pathophysiology -- 1.2.5.4 Treatment -- 1.2.6 Lung Cancer -- 1.2.6.1 Etiology -- 1.2.6.2 Epidemiology -- 1.2.6.3 Pathophysiology -- 1.2.6.4 Treatment -- 1.3 Conclusion -- References -- 2: Natural Polymers for Drugs Delivery -- 2.1 Introduction -- 2.2 Polysaccharide-Based Drug Delivery Systems -- 2.2.1 Alginate-Based Drug Delivery Systems -- 2.2.2 Cyclodextrin-Based Drug Delivery Systems |
|
2.2.3 Chitosan-Based Drug Delivery Systems -- 2.2.4 Dextran-Based Drug Delivery Systems -- 2.2.5 Agarose-Based Drug Delivery Systems -- 2.2.6 Hyaluronic Acid-Based Drug Delivery Systems -- 2.2.7 Starch-Based Drug Delivery Systems -- 2.2.8 Cellulose-Based Drug Delivery Systems -- 2.3 Protein-Based Drug Delivery Systems -- 2.3.1 Collagen-Based DDS -- 2.3.2 Albumin and Gelatin-Based Drug Delivery Systems -- 2.4 Summary and Conclusion -- References -- 3: Drug Delivery Systems Based on Various Natural Polymers for Lung Diseases -- 3.1 Introduction -- 3.2 Merits of Natural Polymers |
|
3.3 Demerits of Natural Polymers -- 3.4 Natural Polymer-Based Drug Delivery Systems for Lung Disease -- 3.4.1 Polymeric Nanoparticles -- 3.4.2 Nanocrystals -- 3.4.3 Polymeric Microparticles -- 3.4.4 Pulsatile Microcapsules -- 3.4.5 Liposomes -- 3.4.6 Microspheres -- 3.4.7 Nanospheres -- 3.4.8 Polymeric Solutions -- 3.4.9 Nanofibers -- 3.5 Devices for Delivery of Drugs -- 3.5.1 Dry Powder Inhalers -- 3.5.2 Nebulizers -- 3.5.3 Metered Dose Inhalers -- 3.6 Advantages of Natural Polymers in Developing Drug Delivery System for Lung Diseases -- 3.7 Conclusion -- References |
|
Part I: Plant-Derived Natural Polymers Employed in Respiratory Diseases -- 4: Cellulose-Based Drug Delivery Systems in Lung Disorders -- 4.1 Introduction -- 4.2 Characteristics of Cellulose -- 4.3 Global Production of Cellulose -- 4.4 Application of Cellulose and its Derivatives in Lung Diseases -- 4.4.1 Cellulose and Lung Cancer -- 4.4.2 Cellulose and Lung Infections -- 4.4.3 Cellulose and Influenza -- 4.4.4 Cellulose and Tuberculosis -- 4.4.5 Cellulose and Lung Tissue Engineering -- 4.4.6 Cellulose and Chronic Obstructive Pulmonary Disease -- 4.4.7 Cellulose and Asthma |
| Summary |
This book comprehensively reviews the recent developments of natural polymers for drug delivery systems in various lung disorders. The initial chapter provides a brief introduction to lung diseases with a focus on the current landscape of natural polymers and trends in understanding the disease pathology. Several chapters of the book devoted to the latest technologies and advances in drug delivery systems include practical solutions on designing more effective drug delivery systems based on natural polymers that can be used in the management of lung diseases. Further, the book presents biodegradable and bio-reducible- natural polymers- based drug delivery systems for lung diseases. Towards the end, the book examines future prospects and challenges of natural polymers-based drug delivery systems in combating lung diseases. This book is useful for phytochemists, formulation/drug delivery, biological and translational researchers and clinicians working in the field of lung disorders |
| Notes |
Online resource; title from PDF title page (SpringerLink, viewed February 16, 2023) |
| Subject |
Polymeric drug delivery systems.
|
|
Lungs -- Diseases -- Treatment
|
|
Lungs -- Diseases -- Treatment
|
|
Polymeric drug delivery systems
|
| Form |
Electronic book
|
| Author |
Dureja, Harish
|
|
Adams, Jon
|
|
Löbenberg, Raimar.
|
|
Andreoli Pinto, Terezinha de Jesus
|
|
Dua, Kamal.
|
| ISBN |
9789811976568 |
|
9811976562 |
|
